Education, Science, Technology, Innovation and Life
Open Access
Sign In

Rocuronium-Induced Anaphylactic Shock Complicated by Coagulopathy and Thrombocytopenia: A Case Report

Download as PDF

DOI: 10.23977/medsc.2026.070301 | Downloads: 0 | Views: 14

Author(s)

Kang Du 1

Affiliation(s)

1 Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Corresponding Author

Kang Du

ABSTRACT

Perioperative anaphylaxis to neuromuscular blocking agents is rare but fatal; its coagulopathic sequelae are under-recognized, and rocuronium is the most frequently incriminated agent. Mast cell tryptase cleaves fibrinogen and activates protease-activated receptor-1, inducing consumption of hemostatic reserves, whereas drug-dependent antibodies may destroy platelets; their concurrent presentation with cardiac arrest is unreported. We report a 72-year-old man who, despite tolerating rocuronium four months earlier, developed fulminant anaphylactic shock with pulseless electrical activity arrest upon re-exposure during induction of elective ileostomy reversal; surgery was aborted immediately. Post-resuscitation tryptase (42.3 μg/L vs baseline 4.1 μg/L) satisfied the anaphylaxis diagnostic algorithm. Severe coagulopathy ensued (fibrinogen 0.79 g/L, platelet count 13×109/L); thromboelastography (TEG) showed hypocoagulability without fibrinolysis. Serial TEG-guided transfusion of irradiated apheresis platelets, fresh frozen plasma and fibrinogen concentrate led to rapid improvement, complete neurological recovery, and discharge on hospital day six. Four-week allergologic workup confirmed rocuronium-specific IgE-mediated hypersensitivity (positive skin prick and intradermal tests, elevated specific IgE, negative cisatracurium testing). Rocuronium re-exposure in sensitized individuals can trigger a multisystem coagulopathic storm; TEG-guided resuscitation and thorough allergy workup are critical for patient safety.

KEYWORDS

Rocuronium; Anaphylactic shock; Hypofibrinogenemia; Drug-induced immune thrombocytopenia; Thromboelastography

CITE THIS PAPER

Kang Du. Rocuronium-Induced Anaphylactic Shock Complicated by Coagulopathy and Thrombocytopenia: A Case Report. MEDS Clinical Medicine (2026). Vol. 7, No. 3, 1-8. DOI: http://dx.doi.org/10.23977/medsc.2026.070301.

REFERENCES

[1] Mertes PM, Alla F, Trechot P, et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011;128(2):366-373.
[2] Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology. 2003;99(3):536-545.
[3] Ebo DG, Clarke RC, Mertes PM, et al. Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: a narrative review. Br J Anaesth. 2019;123(1):e38-e49.
[4] Lee S, Kim JH, Park JS, et al. Causes and diagnostic usefulness of tryptase measurements for anaphylaxis in a Korean tertiary care general hospital. Yonsei Med J. 2022;63(11):1027-1034.
[5] Iarossi MAC, van de Wyngaert C, Hermans C, et al. Hypofibrinogenemia following an anaphylactic shock caused by a neuromuscular blocking agent: a case report. Case Rep Crit Care. 2025;2025:6954832.
[6] Vayne C, Guery EA, Rollin J, et al. Pathophysiology and diagnosis of drug-induced immune thrombocytopenia. J Clin Med. 2020;9(7):2212.
[7] Dewachter P, Mouton-Faivre C, Hepner DL. Perioperative anaphylaxis: what should be known? Curr Allergy Asthma Rep. 2015;15(3):17.
[8] Valent P, Akin C, Bonadonna P, et al. Proposed diagnostic algorithm for patients with suspected mast cell activation. J Allergy Clin Immunol. 2019;143(3):864-874.
[9] Whiting P, Al M, Westwood M, et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(38):1-228.
[10] Gonzalez E, Moore EE, Moore HB, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263(6):1051-1059.
[11] Arnold DM, Nazi I, Warkentin TE, et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013;27(3):137-145.
[12] Garvey LH, Ebo DG, Mertes PM, et al. An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions. Allergy. 2019;74(10):1872-1884.
[13] Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2010;7(6):911-918.
[14] Spindola MAC, Castells MV, Sanchez IC, et al. Suspending or continuing surgery after intraoperative hypersensitivity: a prospective multicentre observational study. Br J Anaesth. 2025;135(6):1331-1334.

Downloads: 12121
Visits: 1083588

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.